Health Canada obtains permanent injunction preventing Canlab Research’s illegal sale of injectable peptides in Canada

On June 11, 2026, the Superior Court of Québec granted Health Canada a permanent injunction against Canlab Research and its representatives. The injunction prevents the company from selling unauthorized injectable peptides in Canada.

July 29, 2026 - Ottawa, ON - Health Canada

On June 11, 2026, the Superior Court of Québec granted Health Canada a permanent injunction against Canlab Research and its representatives. The injunction prevents the company from selling unauthorized injectable peptides in Canada.

Selling unauthorized prescription drugs or making false or misleading claims to prevent, treat or cure illnesses is illegal in Canada.

Canlab Research, a Québec-based online retailer, had been selling unauthorized peptide drugs on various websites and promoting them with many unproven health claims, despite repeated enforcement actions by Health Canada. These actions included a Ministerial Order directing the company to cease advertising and selling unauthorized health products because of the health risks to Canadians.

Under the injunction, Canlab Research and its representatives cannot manufacture, test, distribute or sell unauthorized injectable peptides, nor can it assist others in doing the same. It also cannot advertise or assist others in advertising these products, including through any website or social media platform accessible with a Canadian Internet Protocol (IP) address.

Health Canada will monitor compliance with the injunction and will consider further action if the company does not comply. This could include referring the matter for prosecution or filing an application for contempt.